Non-Invasive Blood-Brain Barrier Disruption Using Acoustic Holography With a Clinical Focused Ultrasound System.
Authors: McDannold N, Zhang Y, Fletcher SM, Wen PY, Reardon DA, Golby AJ, Livingstone M
Holographic methods can be used with phased array transducers to shape an ultrasound field. We tested a simple method to create holograms with a hemispherical 1024-element phased array transducer and explored how it could benefit ultrasound-mediated blood-brain barrier (BBB) disruption. With this method, individual acoustic simulations for each element of the transducer were simultaneously loaded into computer memory. Each element's phase was systematically modulated until the combined field matched a desired pattern. The method was evaluated with a 220 kHz transducer being tested clinically to enhance drug delivery via BBB disruption. The holograms were evaluated in a tissue-mimicking phantom and in vivo in experiments disrupting the BBB in rats and in a macaque. We also explored whether this approach could mitigate secondary reflections from the skull using simulations of transcranial focusing in clinical treatments of transcranial sonication for BBB disruption. This approach can enlarge the focal volume in a patient-specific manner and could reduce the number of sonication targets needed to disrupt large volumes, improve the homogeneity of the disruption, and improve our ability to detect microbubble activity in tissues with low vascular density. Simulations suggest that the method could also mitigate secondary reflections during transcranial sonication.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To test a simple method for creating holograms with a hemispherical 1024-element phased-array transducer and evaluate its potential to improve ultrasound-mediated blood–brain barrier disruption.
Animal model / Human subject
rat; macaque, none, none, none
Disease model
healthy
Outcomes and Safety
Summary of Outcomes
Focused ultrasound improved the uniformity and efficiency of BBB opening.
Duration of biological effect
not reported
Safety-related matter
No adverse effects are reported; the paper notes potential safety-related benefits — the method could mitigate secondary reflections during transcranial sonication and improve detection of microbubble activity, potentially improving homogeneity and reducing the number of sonication targets.
Brain Region
Ultrasound Parameters
Ultrasound instrument
focused ultrasound transducer
FUS Frequency
220 kHz
FUS Intensity
not reported
FUS Pressure
not reported
FUS Mode
not reported
Pulse duration
not reported
Duration of a single FUS session
not reported
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search